Public Release: 

Renowned Prostate Cancer Experts Present Latest Findings At UCSF Cancer Center Symposium

University of California - San Francisco

The latest discoveries related to prostate cancer research, diagnosis and treatment will be presented by several of the nation's leading cancer experts during an all-day symposium at the University of California, San Francisco.

DATE: Tuesday, May 25, 1999
TIME: 9:00 am-5:00 pm
PLACE: Cole Hall, 513 Parnassus Avenue
COST: Free

Researchers will present the most recent information regarding cellular interactions in prostate cancer, new gene discoveries and techniques for measuring patient outcomes. In addition, new results of clinical trials of experimental agents for the treatment of prostate cancer--including immunotherapies and alternative therapies--will be presented.

Speakers at the UCSF Cancer Center symposium include Peter Carroll, M.D., chair, department of urology, UC San Francisco; Alice Whittemore, Ph.D., department of epidemiolgy and health research and policy, Stanford University; and Owen Witte, M.D., department of microbiology and molecular genetics, UC Los Angeles.

Prostate cancer--which will claim an estimated 37,000 lives this year--is a significant health care problem in the U.S. due to high incidence and mortality, costs associated with detection and treatment, and lack of consensus regarding the best form of treatment for each stage of the disease.

In addition, the causes of prostate cancer are multiple, incorporating familial (genetic) elements, as well as probable racial, cultural, and environmental factors, such as diet.

###

UCSF CANCER CENTER SYMPOSIUM
TUESDAY, MAY 25, 1999
UCSF CAMPUS, COLE HALL
9:00 AM-5:00 PM

9:00-9:15 Introduction
9:15-9:30 Personal Computers vs. Prostate Cancer: A Comparison of Approaches and Organization of Work
Andy Grove, Ph.D.
9:30-10:00 Epidemiolgoy of Prostate Cancer: Who's At Risk?
Alice Whittemore, Ph.D.
10:00-10:30 Measuring Patient Outcomes After Diagnosis of Prostate Cancer: Where Have We Been and Where Are We Going?
Peter Carroll, M.D., & Deborah Lubeck, Ph.D.
10:30-11:00 Panel Question-and-Answer Period: Alice Whittemore, Peter Carroll & Deborah Lubeck
Moderator: Mack Roach III, M.D.
11:00-11:15 BREAK
11:15-11:45 Cellular Interactions in Prostate Cancer: Which Cells Are Guilty?
Thea Tlsty, Ph.D.
11:45-12:15 Basic and Clinical Biology of Prostate Stem Cell Antigen
Owen Witte, M.D.
12:15-12:45 Panel Question-and-Answer Period: Thea Tlsty & Owen Witte
Moderator: Gerald Cuhna, Ph.D.
12:45-1:45 LUNCH
1:45-2:15 Metastasis-Related Genes in Prostate Cancer: The Role of Caveolin
Tim Thompson, Ph.D.
2:15-2:45 Immunotherapy in Prostate Cancer
Jim Allison, Ph.D.
2:45-3:15 Panel Question-and-Answer Period: Tim Thompson & Jim Allison
Moderator: Marc Shuman, M.D.
3:15-3:30 BREAK
3:30-4:00 Results of Clinical Trials of Experimental Agents in Prostate Cancer: Is There Hope?
Eric Small, M.D.
4:00-4:30 Alternative or Complementary Medicine for Breast Cancer: The Challenge of Clinical Investigation
Debu Tripathy, M.D.
4:30-5:00 Panel Question-and-Answer Period: Eric Small & Debu Tripathy
Moderator: Charlotte Jacobs, M.D.
5:00 Adjourn


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.